EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Single-pill combination of perindopril, indapamide, and amlodipine in hypertensive patients with obesity: long-term efficacy

S. M. Koval, O. V. Mysnychenko, M. Y. Penkova, V. I. Pankiv, I. V. Chernyavska, O. M. Lytvynova, O. E. Berezin

Clinical Endocrinology and Endocrine Surgery · 30.06.2026 · (2) · 52-62

DOI: 10.30978/cees-2026-2-52 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology and Endocrine Surgery, online erschienen am 30.06.2026. Verfasst von S. M. Koval und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment of patients with arterial hypertension associated with abdominal obesity (AO) is complex and most often requires the use of several antihypertensive agents. Achieving target of blood pressure (BP) is most difficult in cases of association of hypertension with a number of metabolic diseases, the most common of which is AO. When hypertension is combined with AO, there is a more rapid and pronounced development of such pathological changes as activation of the renin-angiotensin-aldosterone system, atherogenic dyslipidemia, insulin resistance, hypeuricemia and subclinical inflammation. Objective — to evaluate the advantages of the single-pill combination (SPC) of perindopril, indapamide and amlodipine in comparison with their free combination (FC) in achieving effective control of hypertension for a long time in patients with AO. Materials and methods. 75 patients (of which 45 men) with uncontrolled hypertension associated with AO (age 48 — 66 years old) were examined. Among patients included in the study, 36 received a FC of perindopril, indapamide and amlodipine, and 39 — SPC of these drugs. The drugs were used once a day in the following daily doses: perindopril — 4 — 8 mg, indapamide — 1.25 — 2.5 mg and amlodipine — 5 — 10 mg. Patients were followed up for 12 months.

Results

SPC of perindopril, indapamide and amlodipine were significantly more effective than FC in hypertensive patients with АO. The high efficiency of SPC persisted for a long time (over the course of 12 months) and associated with significantly increased adherence to therapy in comparison with FC. To achieve target BP levels with SPC, lower doses of drugs were required than with FC.

Conclusions

SPC of P, I and A shows greater efficiency than FC, and makes it possible to maintain BP within the target levels for a long time with lower doses of drugs. The high efficiency of SPC associated with significantly increased adherence to therapy in comparison with FC. To achieve target BP levels with SPC, lower doses of drugs were required than with FC. SPC and FC in patients with hypertension and AO contributed to the inhibition of asymptomatic hypertension-mediated organ damage progression, did not adversely affect metabolic parameters, and were characterized by high safety.

Zitieren

APA

Koval, S. M., Mysnychenko, O. V., Penkova, M. Y., Pankiv, V. I., Chernyavska, I. V., Lytvynova, O. M., & Berezin, O. E. (2026). Single-pill combination of perindopril, indapamide, and amlodipine in hypertensive patients with obesity: long-term efficacy. Clinical Endocrinology and Endocrine Surgery, 52-62. https://doi.org/10.30978/cees-2026-2-52

Vancouver

Koval SM, Mysnychenko OV, Penkova MY, Pankiv VI, Chernyavska IV, Lytvynova OM, et al. Single-pill combination of perindopril, indapamide, and amlodipine in hypertensive patients with obesity: long-term efficacy. Clinical Endocrinology and Endocrine Surgery. 2026:52-62. doi:10.30978/cees-2026-2-52

BibTeX
@article{Koval2026,
  author = {Koval, S. M. and Mysnychenko, O. V. and Penkova, M. Y. and Pankiv, V. I. and Chernyavska, I. V. and Lytvynova, O. M. and Berezin, O. E.},
  title = {Single-pill combination of perindopril, indapamide, and amlodipine in hypertensive patients with obesity: long-term efficacy},
  journal = {Clinical Endocrinology and Endocrine Surgery},
  year = {2026},
  number = {2},
  pages = {52--62},
  doi = {10.30978/cees-2026-2-52}
}
Kostenlos starten →